Skip to content
mapperlab
← Dashboard
Stock

CI

The Cigna Group
Health CareHealth Care ServicesLatest close $2879 of 27 marquee funds currently hold2 CUSIPs mapped
Current holders
9
27 funds tracked
Ever held
15
Current + past
New this quarter
0
Exited this quarter
0

Marquee-fund ownership over time

Aug 13, 2013Nov 14, 2016Feb 14, 2022Feb 17, 2026
Now
9

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Bridgewater Associates re-entered$0.00$287
Glenview Capital re-entered$0.00$287
Renaissance Technologies re-entered$325$287-12%
Citadel Advisors$324$287-11%
Two Sigma Investments$324$287-11%
D.E. Shaw$324$287-11%
AQR Capital Management$324$287-11%
Millennium Management$324$287-11%
Point72 Asset Management$289$287-1%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Maverick Capital 9× in & out→ $314-3%
Scion Asset Management 3× in & out→ $324-2%
Viking Global Investors 4× in & out→ $193-4%
Third Point→ $141-14%
JANA Partners+0%
Greenlight Capital 2× in & out+0%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at Cigna Group. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
3
Filings · last 90d
13
Total on file
599
Recent SEC buffer
Most recent
Jun 3, 2026

30d / 90d windows measured from Jun 3, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 599 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · The Cigna Group

Annual figures sourced directly from The Cigna Group's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$274.9B
FY2025+11% YoY
Net income
$5.96B
FY2025+73% YoY
EPS (diluted)
$22.18
FY2025+83% YoY
Free cash flow(?)
$9.6B
FY2025-7% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for Cigna Group — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Point72 Asset ManagementQ1 2026open$289$287-1%
Renaissance TechnologiesQ2 2025open$297$287-3%
Citadel AdvisorsQ3 2024open$324$287-11%
Two Sigma InvestmentsQ3 2024open$324$287-11%
D.E. ShawQ3 2024open$324$287-11%
AQR Capital ManagementQ3 2024open$324$287-11%
Millennium ManagementQ3 2024open$324$287-11%
Maverick CapitalQ3 2024Q4 2024$324$314-3%
Renaissance TechnologiesQ3 2024Q4 2024$325$322-1%
Scion Asset ManagementQ2 2024Q3 2024$330$324-2%
Maverick CapitalQ4 2023Q1 2024$277$325+17%
Scion Asset ManagementQ2 2023Q4 2023$244$277+13%
Maverick CapitalQ2 2023Q3 2023$244$275+13%
Maverick CapitalQ3 2022Q4 2022$272$288+6%
Scion Asset ManagementQ2 2022Q3 2022$248$272+10%
Bridgewater AssociatesQ3 2021open$193$273+41%
Maverick CapitalQ2 2020Q1 2022$173$209+21%
Bridgewater AssociatesQ2 2020Q4 2020$168$200+19%
Viking Global InvestorsQ1 2020Q3 2021$202$193-4%
Glenview CapitalQ1 2019open$175$287+64%
Maverick CapitalQ1 2019Q1 2020$175$200+15%
Third PointQ1 2019Q2 2019$165$141-14%
Maverick CapitalQ2 2018Q1 2019$0.00+0%
JANA PartnersQ2 2018Q3 2018$0.00+0%
Viking Global InvestorsQ2 2016Q4 2016$0.00+0%
Greenlight CapitalQ1 2016Q3 2017$0.00+0%
Maverick CapitalQ4 2015Q1 2018$0.00+0%
Viking Global InvestorsQ3 2015Q4 2015$0.00+0%
Viking Global InvestorsQ1 2015Q2 2015$0.00+0%
Bridgewater AssociatesQ2 2014Q3 2015$0.00+0%
Maverick CapitalQ1 2014Q2 2014$0.00+0%
Greenlight CapitalQ3 2013Q1 2015$0.00+0%
Glenview CapitalQ3 2013Q1 2019$0.00+0%
Bridgewater AssociatesQ3 2013Q1 2014$0.00+0%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.